RSC Medicinal Chemistry Blog

Congratulations to Daniel Foley and Dr Richard Doveston who were awarded the poster prize at the RSC-BMCS Fragment-based Drug Discovery meeting, held at the STFC Rutherford Appleton Laboratory in Oxfordshire, 3rd-5th March 2013.

Daniel is a PhD research student working under the supervision of Profs. Adam Nelson and Stephen Marsden at the University of Leeds, while Richard took up a post-doctoral research position with Prof. Adam Nelson and Prof. Steve Marsden, in collaboration with GlaxoSmithKline in April 2012. Their poster entitled ‘Realising Lead-Oriented Synthesis’ won the competition. Daniel receives a one-year personal subscription to MedChemComm.

Dr Richard Doveston and Daniel Foley, University of Leeds

Photo provided by the University of Leeds.

Also read the news item featured on the University of Leeds, School of Chemistry homepage.

Congratulations again to Richard and Daniel on their award! The MedChemComm team wishes them all the very best with their future research work.

Oral contribution prize winner Mark Rackham with BMCS Committee member Dave Alker

Kerya, from Dr Andrew Wilson’s group at University of Leeds, was awarded Best Poster Contribution for ‘Development of synthetic α-helix mimetics as potent anticancer agents’. Both winners receive a year’s subscription to MedChemComm.

Poster contribution winner Kerya Long with Dave Alker

The symposium, organised by the RSC’s Biological & Medicinal Chemistry interest group, was held at the University of Cambridge on 14^th December 2012.

I am delighted to report that Dr Martine Keenan from Epichem Pty Ltd (Murdoch, Australia) was the winner of the MedChemComm poster prize at the recent 16th SCI/RSC Medicinal Chemistry Symposium that took place at Churchill College in Cambridge, UK, from 11 to 14 September.

The symposium was jointly organised by the Society of Chemical Industry and the Royal Society of Chemistry, and gave a splendid overview of some of the new strategies in Medicinal Chemistry and Pharmaceutical Research.

Martine’s winning poster entitled ‘Collaborative drug discovery for neglected diseases: novel compounds for the treatment of Chagas Disease’ presents the identification and development of two novel compound series active against the intracellular protozoan parasite Trypanosoma cruzi, the causative agent of the Chagas disease. Endemic in 21 countries across Latin America, the Chagas disease is responsible for more deaths in this region than Malaria, or any other parasite-born disease, and is currently spreading to developed countries including Australia, USA, Japan or Spain. This award winning work is the result of a collaborative drug discovery consortium established by not-for-profit, drug research and development organisation Drugs for Neglected Diseases initiative (DNDi).

Congratulations again to Martine on her award-winning work and to the collaborative drug delivery consortium for their active research on neglected diseases.

Keep up to date with the latest news and research in medicinal chemistry: sign up to the MedChemComm e-alert, check out our blog, and follow us on Twitter.